Association between busulfan exposure and outcome in children receiving intravenous busulfan before haematopoietic stem cell transplantation

被引：0
|
作者：
Ansari, M.
Theoret, Y.
Rezgui, M.
Mezziani, S.
Desjean, C.
Vachon, M.
Labuda, M.
Champagne, M.
Duval, M.
Peters, C.
Krajinovic, M.
Bittencourt, H.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation
    Schechter, Tal
    Finkelstein, Yaron
    Doyle, John
    Verjee, Zulfikarali
    Moretti, Myla
    Koren, Gideon
    Dupuis, L. Lee
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (03) : 307 - 314
  • [32] Using Bayesian software to inform initial busulfan dose in adults receiving haematopoietic stem cell transplantation
    Chin, Paul
    Morahan, Marie-Claire
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 285 - 285
  • [33] Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation
    Cho, Yo-Han
    Lim, Hyun-Ae
    Lee, Mark Hong
    Kim, Inho
    Lee, Jong Seok
    Park, Seong yang
    Kim, Byoung Kook
    Yoon, Sung-Soo
    [J]. CLINICAL TRANSPLANTATION, 2007, 21 (03) : 417 - 422
  • [34] Intravenous busulfan in children prior to haematological stem cell transplantation: a narrow therapeutic window
    Bartelink, I. H.
    Bredius, R. G. M.
    Egberts, A. C. G.
    Suttorp, M. M.
    Bierings, M.
    Belitser, S.
    Knibbe, C. A. J.
    Zwaveling, J.
    Boelens, J. J.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S50 - S50
  • [35] Prospective pharmacokinetic study of intravenous busulfan in hematopoietic stem cell transplantation in 25 children
    Okamoto, Yasuhiro
    Nagatoshi, Yoshihisa
    Kosaka, Yoshiyuki
    Kikuchi, Akira
    Kato, Shunichi
    Kigasawa, Hisato
    Horikoshi, Yasuo
    Oda, Megumi
    Kaneda, Makoto
    Mori, Tetsuya
    Mugishima, Hideo
    Tsuchida, Masahiro
    Taniguchi, Shuichi
    Kawano, Yoshifumi
    [J]. PEDIATRIC TRANSPLANTATION, 2014, 18 (03) : 294 - 301
  • [36] Evaluation of two software using Bayesian methods for monitoring exposure and dosing once-daily intravenous busulfan in paediatric patients receiving haematopoietic stem cell transplantation
    Rachael Lawson
    Lachlan Paterson
    Christopher J. Fraser
    Stefanie Hennig
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 88 : 379 - 391
  • [37] Evaluation of two software using Bayesian methods for monitoring exposure and dosing once-daily intravenous busulfan in paediatric patients receiving haematopoietic stem cell transplantation
    Lawson, Rachael
    Paterson, Lachlan
    Fraser, Christopher J.
    Hennig, Stefanie
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (03) : 379 - 391
  • [38] Glutathione S transferase gene variations influence busulfan pharmacokinetics and outcome of haematopoietic stem cell transplantation
    Krajinovic, M.
    Rezgui, M. A.
    Theoret, Y.
    Duval, M.
    Meziani, S.
    Rousseau, J.
    Labuda, M.
    Pryzbila, C.
    Vachon, M.
    Desjean, C.
    Champagne, M.
    Peters, C.
    Bittencourt, H.
    Ansari, M.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S41 - S41
  • [39] Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantation
    Oechtering, D
    Schiltmeyer, B
    Hempel, G
    Schwab, M
    Würthwein, G
    Mürdter, T
    Klingebiel, T
    Vormoor, J
    Gruhn, B
    Fleischack, G
    Boos, J
    [J]. ANTI-CANCER DRUGS, 2005, 16 (03) : 337 - 344
  • [40] Intravenous Busulfan: A Guide to Its Use as Conditioning Treatment before Transplantation of Haematopoietic Progenitor Cells
    Scott, Lesley J.
    Hoy, Sheridan M.
    Lyseng-Williamson, Katherine A.
    [J]. CLINICAL DRUG INVESTIGATION, 2012, 32 (09) : 641 - 648
12345